Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

Fine-tuning of GPCR signals by intracellular G protein modulators.

Zhao P, Cladman W, Van Tol HH, Chidiac P.

Prog Mol Biol Transl Sci. 2013;115:421-53. doi: 10.1016/B978-0-12-394587-7.00010-5. Review.

PMID:
23415100
2.

Transactivation of PDGFRbeta by dopamine D4 receptor does not require PDGFRbeta dimerization.

Chi SS, Vetiska SM, Gill RS, Hsiung MS, Liu F, Van Tol HH.

Mol Brain. 2010 Jul 26;3:22. doi: 10.1186/1756-6606-3-22.

3.
4.

The dopamine D4 receptor activates intracellular platelet-derived growth factor receptor beta to stimulate ERK1/2.

Gill RS, Hsiung MS, Sum CS, Lavine N, Clark SD, Van Tol HH.

Cell Signal. 2010 Feb;22(2):285-90. doi: 10.1016/j.cellsig.2009.09.031. Epub 2009 Sep 24.

PMID:
19782129
5.

Dopamine counteracts octopamine signalling in a neural circuit mediating food response in C. elegans.

Suo S, Culotti JG, Van Tol HH.

EMBO J. 2009 Aug 19;28(16):2437-48. doi: 10.1038/emboj.2009.194. Epub 2009 Jul 16.

6.

Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP.

Park HJ, Georgescu SP, Du C, Madias C, Aronovitz MJ, Welzig CM, Wang B, Begley U, Zhang Y, Blaustein RO, Patten RD, Karas RH, Van Tol HH, Osborne TF, Shimano H, Liao R, Link MS, Galper JB.

J Clin Invest. 2008 Jan;118(1):259-71.

7.

Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D2 and D4 receptors.

Cho DI, Beom S, Van Tol HH, Caron MG, Kim KM.

Biochem Biophys Res Commun. 2006 Nov 24;350(3):634-40. Epub 2006 Sep 26.

PMID:
17022946
9.

Microarray analysis of the developing cortex.

Semeralul MO, Boutros PC, Likhodi O, Okey AB, Van Tol HH, Wong AH.

J Neurobiol. 2006 Dec;66(14):1646-58.

10.

Influence of the antipsychotic drug pipamperone on the expression of the dopamine D4 receptor.

Van Craenenbroeck K, Gellynck E, Lintermans B, Leysen JE, Van Tol HH, Haegeman G, Vanhoenacker P.

Life Sci. 2006 Dec 3;80(1):74-81. Epub 2006 Aug 25.

PMID:
16978659
11.
12.

The interaction between TPH2 promoter haplotypes and clinical-demographic risk factors in suicide victims with major psychoses.

De Luca V, Hlousek D, Likhodi O, Van Tol HH, Kennedy JL, Wong AH.

Genes Brain Behav. 2006 Feb;5(1):107-10.

13.

Tryptophan hydroxylase 2 gene expression and promoter polymorphisms in bipolar disorder and schizophrenia.

De Luca V, Likhodi O, Van Tol HH, Kennedy JL, Wong AH.

Psychopharmacology (Berl). 2005 Dec;183(3):378-82. Epub 2005 Oct 21.

PMID:
16240163
14.

Genetic and post-mortem mRNA analysis of the 14-3-3 genes that encode phosphoserine/threonine-binding regulatory proteins in schizophrenia and bipolar disorder.

Wong AH, Likhodi O, Trakalo J, Yusuf M, Sinha A, Pato CN, Pato MT, Van Tol HH, Kennedy JL.

Schizophr Res. 2005 Oct 15;78(2-3):137-46.

PMID:
16054338
15.
16.

Gene expression of tryptophan hydroxylase 2 in post-mortem brain of suicide subjects.

De Luca V, Likhodi O, Van Tol HH, Kennedy JL, Wong AH.

Int J Neuropsychopharmacol. 2006 Feb;9(1):21-5. Epub 2005 Jun 8.

PMID:
15941494
17.

Cortical gene expression in the neonatal ventral-hippocampal lesion rat model.

Wong AH, Lipska BK, Likhodi O, Boffa E, Weinberger DR, Kennedy JL, Van Tol HH.

Schizophr Res. 2005 Sep 15;77(2-3):261-70.

PMID:
15890497
18.

Protein-protein coupling/uncoupling enables dopamine D2 receptor regulation of AMPA receptor-mediated excitotoxicity.

Zou S, Li L, Pei L, Vukusic B, Van Tol HH, Lee FJ, Wan Q, Liu F.

J Neurosci. 2005 Apr 27;25(17):4385-95.

19.

Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis.

Van Craenenbroeck K, Clark SD, Cox MJ, Oak JN, Liu F, Van Tol HH.

J Biol Chem. 2005 May 13;280(19):19350-7. Epub 2005 Mar 8.

20.

Dopamine receptors in C. elegans.

Suo S, Ishiura S, Van Tol HH.

Eur J Pharmacol. 2004 Oct 1;500(1-3):159-66. Review.

PMID:
15464029

Supplemental Content

Loading ...
Support Center